Outlook Therapeutics® to Present at the SVB Securities
– Russ Trenary, President and Chief Executive Officer of Outlook Therapeutics to present on Tuesday, February 14th at 4:20 PM ET –......
Clearside Biomedical OASIS Data to be Presented at Multiple
ALPHARETTA, Ga, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the delivery of......
2022 Fourth Quarter Earnings Conference Call Tuesday,
BETHLEHEM, Pa., Feb. 07, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering......
iTeos to Present at SVB Securities Global Biopharma
WATERTOWN, Mass. and GOSSELIES, Belgium, Feb. 07, 2023 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical......
CENTOGENE to Participate in Upcoming Conferences in
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the essential life science partner for......
Synaptics Strengthens Leadership Team with Addition of Lori
SAN JOSE, Calif., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Synaptics® Incorporated (Nasdaq: SYNA) announced that it strengthened its leadership team with the......
Hyperfine Swoop® Point-of-Care MRI System™ Takes the Stage
Research highlights the significance and clinical relevance of portable MRI technology......
Perella Weinberg Partners to Present at the Credit Suisse
NEW YORK, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Perella Weinberg Partners (“PWP”) (NASDAQ:PWP), a leading global independent advisory firm, today announced......
MacroGenics to Participate in Upcoming Investor
ROCKVILLE, MD, Feb. 06, 2023 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing......
Arvinas to Participate in Upcoming Investor Conferences
NEW HAVEN, Conn., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs......